Unite States Soft Tissue Sarcoma Market Expected to Witness Rapid Growth until 2025
Government's focus on R&D activities in healthcare and increasing approvals for manufacture of generic drugs to drive United States soft tissue sarcoma market According to TechSci Research report, “ United States Soft Tissue Sarcoma Market By Treatment (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drug, Radiation Therapy), By Disease Type (Local Sarcoma, Regional Sarcoma, Metastatic Sarcoma), By End User (Hospitals, Oncology Center, Long Term Care Center), By Region, Forecast & Opportunities, 2025 ” , the market is expected to witness a robust CAGR during the forecast period as the government is focusing on investing in research and development activities to find the better treatments for different types of cancer, including soft tissue sarcoma. The rising awareness among people about such diseases and increasing per capita disposable income is also making United States a favorable market for companies manufacturing drugs for soft tissue sarcoma. Ad...